Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2023-11-20 00:00:00 ET · period of report 2023-11-16 · accession 0001209191-23-055948 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-20 | 2023-11-16 | HRTX | Forbes William P | EVP, Chief Development Off | P - Purchase | $0.94 | +50.0K | 54.0K | +1,250% | +$47.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-16 | P | A | 50,000 | $0.94 | 54,000 | D | — | — | (F1) The range of purchase prices paid was $0.9348 to $0.94. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased at each separate price. |